DMK Pharmaceuticals Corporation Common Stock
DMK was delisted on the 6th of February, 2024.
32 hedge funds and large institutions have $5.68M invested in DMK Pharmaceuticals Corporation Common Stock in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
28% more call options, than puts
Call options by funds: $132K | Put options by funds: $103K
14% more funds holding
Funds holding: 28 → 32 (+4)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
64% less capital invested
Capital invested by funds: $15.7M → $5.68M (-$10M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$981K |
| 2 |
PVI
Pura Vida Investments
New York
|
+$494K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$396K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$208K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$203K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$3.81M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$2.39M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$252K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$195K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$74.2K |
DMK Hedge Fund Activity: Q2 2016 in Review
32 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q2 2016, worth a combined $5.68M — down 64% from $15.7M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DMK positions and 6 closed out — a net gain of 4 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Walleye Trading, adding an estimated $981K. The largest seller was Sio Capital Management, cutting an estimated $3.81M.
- 32 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q2 2016, up from 28 in Q1 2016.
- Funds reported $5.68M of DMK Pharmaceuticals Corporation Common Stock stock for Q2 2016, down 64% quarter-over-quarter.
- 10 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q2 2016 and 6 closed out, a net change of +4 holders.
- The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q2 2016 was Walleye Trading, an estimated $981K added.
- The largest DMK Pharmaceuticals Corporation Common Stock seller in Q2 2016 was Sio Capital Management, an estimated $3.81M sold.
Based on aggregated 13F filings for Q2 2016.